<--- Back to Details
First PageDocument Content
Clinical research / Pharmacy / Innovative Medicines Initiative / Science and technology in Europe / European Federation of Pharmaceutical Industries and Associations / Critical Path Institute / Food and Drug Administration / Pharmacovigilance / European Medicines Agency / Pharmaceutical sciences / Pharmacology / Pharmaceutical industry
Date: 2014-02-20 17:49:57
Clinical research
Pharmacy
Innovative Medicines Initiative
Science and technology in Europe
European Federation of Pharmaceutical Industries and Associations
Critical Path Institute
Food and Drug Administration
Pharmacovigilance
European Medicines Agency
Pharmaceutical sciences
Pharmacology
Pharmaceutical industry

FOR IMMEDIATE RELEASE Contact: Lisa Romero Communications & Development Manager[removed]removed]

Add to Reading List

Source URL: c-path.org

Download Document from Source Website

File Size: 209,59 KB

Share Document on Facebook

Similar Documents

Press Release 14 June 2016 European public and private organisations are collaborating in VAC2VAC, a new project funded by the Innovative Medicines Initiative (IMI2) VAC2VAC is a wide-ranging collaborative research proje

DocID: 1tbPu - View Document

The Innovative Medicines Initiative IMI is working to improve health by speeding up the development of, and patient access to, the next generation of medicines, particularly in areas where there is an unmet medical or so

DocID: 1sOuL - View Document

IMI2 9th Call for proposals Approved by the IMI2 Governing Board of the Innovative Medicines Initiative 2 Joint Undertaking onAnnex 1 to the Decision of the IMI2 JU Governing Board no.

DocID: 1shWP - View Document

Aktuelle Förderprogramme Newsletter - AusgabeMathematik und Naturwissenschaften • Innovative Medicines Initiative 2 (IMI2) • MOST (Taiwan)-Forschungsstipendium • Kurzzeitdozenturen

DocID: 1rWow - View Document

Health care / Health / Business / Pharmaceutical industry / European Federation of Pharmaceutical Industries and Associations / Pharmaceuticals policy / Clinical trials / Innovative Medicines Initiative / Pharmaceutical Research and Manufacturers of America / Pharmacovigilance / Novartis / EuropaBio

EFPIA Annual Report 2015 @EFPIA Introduction

DocID: 1r71B - View Document